BRIACELL THERAP Research and Development (R&D) Expenses Growth

Research and Development (R&D) Expenses Growth of BCTX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Research and Development (R&D) Expenses Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Research and Development (R&D) Expenses Growth for the quarter ending October 31, 2022 was 256.14% (a -34.98% decrease compared to previous quarter)
  • Year-over-year quarterly Research and Development (R&D) Expenses Growth decreased by -72.63%
  • Annual Research and Development (R&D) Expenses Growth for 2022 was 296.93% (a -1879.09% decrease from previous year)
  • Annual Research and Development (R&D) Expenses Growth for 2021 was -16.69% (a -51.89% decrease from previous year)
  • Annual Research and Development (R&D) Expenses Growth for 2020 was -34.69% (a -166.78% decrease from previous year)
  • Twelve month Research and Development (R&D) Expenses Growth ending October 31, 2022 was 404.17% (a -21.62% decrease compared to previous quarter)
  • Twelve month trailing Research and Development (R&D) Expenses Growth increased by 70.35% year-over-year
Trailing Research and Development (R&D) Expenses Growth for the last four month:
31 Oct '22 31 Jul '22 30 Apr '22 31 Jan '22
404.17% 515.64% 352.29% 237.26%
Visit stockrow.com/BCTX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Research and Development (R&D) Expenses Growth of BRIACELL THERAP

Most recent Research and Development (R&D) Expenses Growthof BCTX including historical data for past 10 years.

Interactive Chart of Research and Development (R&D) Expenses Growth of BRIACELL THERAP

BRIACELL THERAP Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 256.14% 393.94% 525.77% 935.91% 296.93%
2021 495.4% 6.61% 97.97% -82.08% -16.69%
2020 -80.18% -39.05% -75.26% -24.92% -34.69%
2019 -1.3% -6.41% 58.21% 106.46% 51.95%
2018 103.69% 45.53% -9.68% 269.85% 52.54%
2017 85.57% 67.18% 2768.32% 5.08% 124.42%
2016 35.21% 66.31% -8.18% 163.57% 120.47%
2015 0.0% 0.0% 0.0% 0.0% 0.0%
2014 0.0% 0.0% 0.0% 0.0% 0.0%
2013 0.0% 0.0% 0.0% 0.0% 0.0%
2012 0.0% 0.0% 0.0% 0.0% 0.0%

Business Profile of BRIACELL THERAP

Sector: Healthcare
Industry: Biotechnology